Source: Lori Butcher / Shutterstock.com
Tilray (NASDAQ:TLRY) stock could rise or fall in 2023, based on whether American legislators make progress with pro-cannabis bills.
While TLRY is a Canadian company, it sells cannabis-related products throughout North America. Thus, U.S. marijuana laws are highly relevant to Tilray and its stakeholders. So far, this looks like a steep uphill battle, and that’s bad news for Tilray.
If any company provides a lesson about what can happen when traders buy New here? Already have an account?This content is restricted to paid subscribers